Cansino Biologics Inc. Posted 1.5 Billion Yuan Net Loss in First Three Quarters of 2023

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net loss of 1.5 billion yuan in the first three quarters of 2023, widening 197.7% year-on-year.

Meanwhile, the company posted 175.6 million yuan in revenue, down 75.2% year-on-year.

At the end of the reporting period, it had 9.6 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 39.7%.